Correlation Between MacroGenics and Candel Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MacroGenics and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MacroGenics and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MacroGenics and Candel Therapeutics, you can compare the effects of market volatilities on MacroGenics and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MacroGenics with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MacroGenics and Candel Therapeutics.

Diversification Opportunities for MacroGenics and Candel Therapeutics

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between MacroGenics and Candel is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding MacroGenics and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and MacroGenics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MacroGenics are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of MacroGenics i.e., MacroGenics and Candel Therapeutics go up and down completely randomly.

Pair Corralation between MacroGenics and Candel Therapeutics

Given the investment horizon of 90 days MacroGenics is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, MacroGenics is 1.41 times less risky than Candel Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  520.00  in Candel Therapeutics on September 6, 2024 and sell it today you would lose (30.00) from holding Candel Therapeutics or give up 5.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MacroGenics  vs.  Candel Therapeutics

 Performance 
       Timeline  
MacroGenics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in MacroGenics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, MacroGenics showed solid returns over the last few months and may actually be approaching a breakup point.
Candel Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Candel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

MacroGenics and Candel Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MacroGenics and Candel Therapeutics

The main advantage of trading using opposite MacroGenics and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MacroGenics position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.
The idea behind MacroGenics and Candel Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies